Can oxybutynin cause peripheral neuropathy?
Patel
H R H
HR
Department of Urology, Whittington Hospital NHS Trust, and Institute of Urology and Nephrology, London, United Kingdom.
Albehussi
S
S
Arya
M
M
Miller
R A
RA
D000283:Administration, Intravesical; D000368:Aged; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005528:Foot / Q000294:innervation*; D006801:Humans; D008333:Mandelic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D010276:Parasympatholytics / Q000009:adverse effects* / Q000627:therapeutic use; D010292:Paresthesia / Q000139:chemically induced*; D013035:Spasm / Q000188:drug therapy* / Q000209:etiology; D007507:Therapeutic Irrigation; D001745:Urinary Bladder Diseases / Q000188:drug therapy* / Q000209:etiology; D001749:Urinary Bladder Neoplasms / Q000150:complications
D008333:Mandelic Acids; D010276:Parasympatholytics; C005419:oxybutynin